Skip to content

Mannkind MNKD EBITDA margin

EBITDA margin at other companies

Eli Lilly logo
Eli LillyLLY
45.9%+14.4pp
LQD
Liquidia CorporationLQDA
-152.5%-66.9pp
Tenet Healthcare logo
Tenet HealthcareTHC
22.1%+0.5pp
Lexicon Pharmaceuticals logo
Lexicon PharmaceuticalsLXRX
-34%-16.5pp
Tandem Diabetes Care logo
Tandem Diabetes CareTNDM
-6.4%-2.4pp
Eton Pharmaceuticals, Inc. logo
Eton Pharmaceuticals, Inc.ETON
-0.6%-0.3pp

Other financials

Income statement

See full
Revenue$90.2M+15.1%
Gross profit$82.7M+10.8%
Operating income-$1.7M-107%
Net income-$16.6M-226%
EPS (diluted)-$0.05-225%

Balance sheet

See full
Cash & equivalents$52.8M+11.7%
Total debt$12.2M-9.4%
Total equity-$59.2M-1.0%
Total assets$744.4M+81.5%

Cash flow

See full
Operating cash flow-$5.4M+15.9%
CapEx$1.9M+470%
Free cash flow-$7.2M-8.0%

Valuation

See full
Market cap$1.21B+6.0%
Enterprise value$1.17B+5.5%
P/E233.9×
P/S3.4×-0.5×

Profitability

See full
Gross margin91.5%-2.6pp
Operating margin23.3%+3.1pp
Net margin9.3%
FCF margin13.8%

Returns & leverage

See full
Return on equity-8.8%
Debt / equity-0.2×
Current ratio1.9×-0.5×

Where this comes from

Calculated from Mannkind’s reported figures.

Based on trailing twelve months.

The official record: Mannkind’s 10-Q, filed November 5, 2025, on SEC EDGAR. View the filing →

Ask your AI about Mannkind's ebitda margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Mannkind's EBITDA margin?
Mannkind (MNKD) reported EBITDA margin of 25.9% in Q3 2025.
How has Mannkind's EBITDA margin changed year-over-year?
Mannkind's EBITDA margin increased by 14.8% year-over-year, from 22.6% to 25.9%.
What is the long-term trend for Mannkind's EBITDA margin?
Over 3 years (2020 to 2024), Mannkind's EBITDA margin has grown at a -26.4% compound annual growth rate (CAGR), from -70.3% to 28%.
What does EBITDA margin mean?
EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.